ICU Medical (ICUI) Q2 2026 earnings — TrendMatrix coverage

Adjusted EPS

$2.37

Estimate

$1.91

Surprise

+23.8%

Revenue (period 2026-06-30)

$551.7M

Score at report (before → after)

4.7 → 4.4/10

Revenue source: xbrl.

ICU Medical (ICUI) beat the $1.91 estimate with adjusted EPS of $2.37 — a large 23.8% upside surprise. TrendMatrix's engine moved from Hold (4.7/10) to Sell at 4.4/10 after the report — the engine's score fell despite the beat.

TrendMatrix currently rates ICUI Sell at 4.7/10.

4 of the last 4 quarters beat the estimate; this quarter's +23.8% surprise compares with a +22.7% four-quarter average. Next scheduled report: 2026-11-05.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$160.84

Price target

$168.24

Stop

$152.48

Upside to target

+4.6%

Reward-to-risk

0.9:1

Model outputs from TrendMatrix’s engine as of 2026-10-21 — shown for context, not personalized investment advice.

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry

Medical Instruments & Supplies

Market cap

$4.03B

P/E (fwd)

16.7

P/E (ttm)

135.4

52-week range

$113.37–$192.85

Off 52-week high

16.6%

RSI (14)

56

Volume vs avg

0.95×

Score today

4.7/10